cbdMD Announces Company’s CEO Joins the Board of Directors 
Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution
FINTEPLA is approved in the U.S. and European Union as an add-on therapy for the treatment of seizures associated with...
T2 Biosystems Announces Meta-analysis of Controlled Studies in Peer-Reviewed Medical Journal Highlighting the Benefits of T2MR Technology Compared to Blood Culture
Study concludes the utilization of T2 Magnetic Resonance (T2MR®) provides faster time to detection, faster time to targeted therapy, and...
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
Dr. Curley brings extensive pharmaceutical industry experience in product development, commercialization and operations as VistaGen advances late-stage development of its...
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
Additional case studies support the broad potential of AC5® Advanced Wound System in chronic and non-healing woundsFRAMINGHAM, Mass., April 27,...
Sotera Health Announces Q1 2021 Earnings Release Date and Participation in the RBC Capital Markets Global Healthcare Conference
CLEVELAND, April 27, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Matinas BioPharma to Webcast Conference Call Discussing First Quarter 2021 Financial and Operational Results on May 10, 2021
BEDMINSTER, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on...
Afya Announces a $150 Million Investment from the SoftBank Latin America Fund
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, April 27, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the...
InMed Pharmaceuticals Announces Voluntary Delisting from TSX
All common shares will continue to be listed and tradable on the NasdaqVANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE)...
Brickell Biotech Completes Patient Enrollment in U.S. Phase 3 Pivotal Cardigan I Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
Phase 3 Pivotal Cardigan II study exceeds 50% enrollment- - -Topline results for Phase 3 Pivotal Cardigan I and Cardigan...
AIM ImmunoTech Announces Positive Safety Data in Second Cohort of Phase 1 Clinical Study Investigating Intranasal Administration of Ampligen as a Potential Prophylaxis or Treatment for COVID-19 and Other Respiratory Viral Diseases
OCALA, Fla., April 27, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has completed...
Antios Therapeutics Continues Building Experienced Executive Team with Appointments of Katie Laessig, M.D., as SVP, Global Regulatory Affairs and Karen Fusaro as SVP, Clinical Operations
Responsible for managing clinical development and the regulatory processes for ATI-2173, an ASPIN, which is in development as part of...
Analytica Announces Expansion of Enhanced Infusion System into Middle East
Enhanced Infusion System (EIS) Patented IV add-in infusion system reduces the risk of infection and embolism, saves time and money....
Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
Arch Oncology Secures $105 Million Series C Financing
– Proceeds to support clinical progress of differentiated anti-CD47 candidate AO-176 for patients with solid tumors and hematologic malignancies – –...
Instil Bio Receives Orphan Drug Designation for ITIL-168 in Melanoma
DALLAS, April 27, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL) received orphan drug designation (ODD) from the...
IGM Biosciences to Present at the Truist Securities Life Sciences Summit
MOUNTAIN VIEW, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on...
Finch Therapeutics Appoints Susan E. Graf to Board of Directors
SOMERVILLE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...
PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™
TORONTO, April 27, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a specialty...
Surface Oncology Expands Leadership Team with Key Executive Appointment and Promotions
Henry Rath announced as chief business officer, Alison O’Neill as chief medical officer and Jessica Fees as chief financial officerCAMBRIDGE,...
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
Axsome to host conference call and webcast on Monday, May 10, 2021 at 8:00 AM Eastern Time NEW YORK, April...